What's new

Human medicines European public assessment report (EPAR): Laventair Ellipta (previously Laventair), umeclidinium bromide,vilanterol, Date of authorisation: 08/05/2014, Revision: 20, Status: Authorised

Human medicines European public assessment report (EPAR): Laventair Ellipta (previously Laventair), umeclidinium bromide,vilanterol, Date of authorisation: 08/05/2014, Revision: 20, Status: Authorised

Mar 27, 2025 - 17:41
 0
Human medicines European public assessment report (EPAR): Laventair Ellipta (previously Laventair), umeclidinium bromide,vilanterol, Date of authorisation: 08/05/2014, Revision: 20, Status: Authorised
Human medicines European public assessment report (EPAR): Laventair Ellipta (previously Laventair), umeclidinium bromide,vilanterol, Date of authorisation: 08/05/2014, Revision: 20, Status: Authorised
Read More

Tags:

Previous Article

Here's How Long All Of Max Verstappen's Teammates Have Lasted

Next Article

Human medicines European public assessment report (EPAR): Anoro Ellipta (previou...

Related Posts

Orphan designation: Autologous CD34+ cells transduced with a lentiviral vector containing the human RAG1 gene Treatment of recombination-activating gene 1 deficient severe combined immunodeficiency, 26/03/2014 Positive

Orphan designation: Autologous CD34+ cells transduced w...

Feb 20, 2025  0

Demonstration of efficacy for veterinary medicinal products containing antimicrobial substances - Scientific guideline

Demonstration of efficacy for veterinary medicinal prod...

Feb 21, 2025  0

Human medicines European public assessment report (EPAR): Recarbrio, imipenem,cilastatin,relebactam, Date of authorisation: 13/02/2020, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 7, 2025  0